ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $293,000 | +23.1% | 9,300 | 0.0% | 0.03% | -17.1% |
| Q3 2023 | $238,000 | -40.6% | 9,300 | -33.5% | 0.04% | -25.5% |
| Q2 2023 | $401,000 | +19.7% | 13,975 | 0.0% | 0.05% | +11.9% |
| Q1 2023 | $335,000 | -84.0% | 13,975 | -68.1% | 0.04% | -87.7% |
| Q3 2021 | $2,093,000 | +5.2% | 43,800 | -25.5% | 0.34% | +15.6% |
| Q2 2021 | $1,990,000 | +140.9% | 58,800 | +194.0% | 0.30% | +109.2% |
| Q1 2021 | $826,000 | – | 20,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Portolan Capital Management | 484,907 | $11,807,485 | 0.97% |
| Nikko Asset Management Americas, Inc. | 1,563,065 | $37,966,849 | 0.44% |
| Diametric Capital, LP | 32,765 | $797,827 | 0.43% |
| ARK Investment Management | 1,964,964 | $47,846,871 | 0.42% |
| SummerHaven Investment Management, LLC | 23,400 | $569,790 | 0.38% |
| Quantedge Capital Pte Ltd | 40,800 | $993,480 | 0.36% |
| Granahan Investment Management | 344,549 | $8,389,768 | 0.34% |
| FEDERATED HERMES, INC. | 4,694,060 | $114,300,361 | 0.27% |
| Belmont Capital, LLC | 40,000 | $974,000 | 0.18% |
| Woodline Partners LP | 754,023 | $18,360,460 | 0.18% |